Sensum
Sensum specialises in the development and production of automatic visual inspection systems for the pharmaceutical and nutraceutical industry. Through its consistent innovation many leading multinational pharmaceutical companies (Pfizer, Novartis, Roche, Bayer, Eli Lilly, Teva, etc.) have recognised Sensum as the technology leader and a preferred supplier of machines for automatic visual inspection. Sensum provides high and mid capacity solutions for 100 % quality inspection of tablets, capsules, transparent capsules and softgels and in-line PAT solution for real-time visual monitoring of pharmaceutical processes.
Trending Articles
Related Content
Analysis
Visual inspection: The reality vs ideal
Visual inspection is about finding defective products and removing them from the production process. We can perform visual inspection manually or automatically with camera systems. Many companies use automatic visual inspection for different reasons, typically to reduce costs, improve detection, increase production throughput, meet market demands or even improve brand reputation
Digital
Automation keeps the pharmaceutical production running during the COVID-19 pandemic
The risk of person-to-person viral transmission during the COVID-19 pandemic is especially relevant in manual, labour intensive and invasive processes such as packaging, labelling and inspection of products where close proximity among employees is difficult to avoid. Process automation can play a key role in risk reduction and help sustain the manufacture, testing and distribution of medications.